Le Lézard
Classified in: Health
Subjects: NPT, LEG

Federal grant will expand eating disorder training for healthcare providers


ST. PAUL, Minn., July 19. 2018 /PRNewswire/ -- The Substance Abuse and Mental Health Services Administration (SAMHSA) announced plans today to create a National Center of Excellence for Eating Disorders, focused on developing and disseminating eating disorder training and technical assistance for healthcare practitioners through a grant of up to $3.75 million awarded to a non-profit agency or university. The Center will work to identify model eating disorder programs, develop educational resources, and provide access to quality training for health professionals.

The Emily Program logo

The Center is made possible by the 21st Century Cures Act, which includes language allowing for the expansion of federally funded professional training on eating disorder recognition and treatment. Expanded education was identified as a significant need because early identification and intervention by practitioners greatly increase the likelihood of eating disorder recovery.

Since the passage of the 21st Century Cures Act in 2016, activists have lobbied for action. The Eating Disorders Coalition, of which The Emily Program and The Emily Program Foundation are driving forces, was a major contributor to the implementation of the Act, working with Congress to urge SAMHSA to establish the Center.

"This is a great advancement for people with eating disorders. Increased training of healthcare professionals and early recognition of these illnesses will save lives. This is a fantastic example of the power of advocacy and being at the table," said Jillian Lampert, Chief Strategy Officer of The Emily Program.

In the United States, an estimated 30 million people will struggle with an eating disorder, and approximately one person dies every hour from eating disorder complications. More than 70% of those affected will not seek treatment because of stigma, access barriers, or misinformation. Healthcare providers are have become a focus of addressing this problem because of their ability to recognize and treat eating disorder symptoms early.

"In our work and community, we frequently hear from those affected by eating disorders that more needs to be done to equip people for eating disorder prevention and early intervention. We're thrilled that this new center of excellence will increase training and resources for health care professionals," said Lisa Radzak, Executive Director of The Emily Program Foundation.

SAMHSA, which is a branch of the U.S. Department of Health and Human Services, is accepting initial grant applications through August 17, 2018.

About The Emily Program
The Emily Program was founded in 1993 by Dirk Miller, PhD, LP, after his sister Emily recovered from an eating disorder. Recognizing that one size does not fit all, The Emily Program develops a personalized, evidence-based care plan for its clients that incorporates individual and group therapy, nutrition, yoga and more. If you or someone you know is struggling with an eating disorder, call 1-888-EMILY-77 or visit emilyprogram.com.

About The Emily Program Foundation
The Emily Program Foundation is a Minnesota-based nonprofit working to end eating disorders. The Foundation empowers prevention, supports recovery, and advocates for legislative change. It strives to reduce the stigma of eating disorders by sharing stories of struggle, strength, and hope. For more information, visit emilyprogramfoundation.org.

Contact: Jillian Lampert
Phone: 651-645-5323 ext. 1133
Email: [email protected]

 

SOURCE The Emily Program


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: